Subscribe to RSS Please copy the URL and add it into your RSS Feed Reader. https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000131.xml Share / Bookmark Facebook X Linkedin Weibo Download PDF Synfacts 2024; 20(07): 0760DOI: 10.1055/s-0043-1763969 Innovative Drug Discovery and Development LXRβ-Selective Tricyclic Agonist Developed with New [4σ+4π] and [4σ+4π–1] Cycloaddition Strategy Contributor(s): Dirk Trauner , Joseph A. Flores › Further Information Abstract Full Text Buy Article Permissions and Reprints Key words type-I cycloaddition - [4σ+4π] cycloaddition - benzocyclobutenone - LXR agonist Publication History Article published online:14 June 2024 © 2024. Thieme. All rights reserved Georg Thieme Verlag KGRüdigerstraße 14, 70469 Stuttgart, Germany